Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in non-VA and VA Populations.

MDM Policy & Practice
Shan LiuJeremy D Goldhaber-Fiebert

Abstract

Chronic hepatitis C viral (HCV) infection affects millions of Americans. Healthcare systems face complex choices between multiple highly efficacious, costly treatments. This study assessed the cost-effectiveness of HCV treatments for chronic, genotype 1 HCV monoinfected, treatment-naïve individuals in the Department of Veterans Affairs (VA) and general U.S. healthcare systems. We conducted a decision-analytic Markov model-based cost-effectiveness analysis, employing appropriate payer perspectives and time horizons, and discounting benefits and costs at 3% annually. Interventions included: Sofosbuvir/ledipasvir (SOF-LDV); ombitasvir/paritaprevir/ritonavir/dasabuvir (3D); sofosbuvir/simeprevir (SOF-SMV); sofosbuvir/pegylated interferon/ribavirin (SOF-RBV-PEG); boceprevir/pegylated interferon/ribavirin (BOC-RBV-PEG); and pegylated interferon/ribavirin (PEG-RBV). Outcomes were sustained virologic response (SVR), advanced liver disease, costs, quality adjusted life years (QALYs), and incremental cost-effectiveness. SOF-LDV and 3D achieve higher SVR rates compared to older regimens and reduce advanced liver disease (>20% relative to no treatment), increasing QALYs by over 2 years per person. For the non-VA population, at current pric...Continue Reading

References

Oct 9, 2002·American Journal of Epidemiology·Joshua A SalomonSue J Goldie
Apr 21, 2004·Medical Care Research and Review : MCRR·Todd H WagnerPaul G Barnett
Apr 21, 2004·Medical Care Research and Review : MCRR·Ciaran S PhibbsPaul G Barnett
May 14, 2004·Current Medical Research and Opinion·Edward P Armstrong, Scott L Charland
Feb 21, 2008·Journal of Clinical Gastroenterology·Ramsey C CheungUNKNOWN VA HCV-001 Study Group
Apr 22, 2008·Medical Decision Making : an International Journal of the Society for Medical Decision Making·David J McLernonPeter T Donnan
Jan 28, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Debanjali MitraVinod Rustgi
Mar 15, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lisa I BackusLarry A Mole
Apr 1, 2011·The New England Journal of Medicine·Fred PoordadUNKNOWN SPRINT-2 Investigators
Jun 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samer S El-KamaryMichelle D Shardell
Aug 16, 2011·Clinical Therapeutics·Jeffrey S McCombsSammy Saab
Nov 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hamish A InnesUNKNOWN Hepatitis C Clinical Database Monitoring Committee
Feb 22, 2012·Annals of Internal Medicine·Shan LiuJeremy D Goldhaber-Fiebert
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
May 28, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Kee ChanSamuel B Ho
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 12, 2014·The New England Journal of Medicine·Jordan J FeldBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
May 6, 2014·The New England Journal of Medicine·Peter FerenciUNKNOWN PEARL-IV Study
Mar 17, 2015·Annals of Internal Medicine·Mehdi NajafzadehNiteesh K Choudhry
Mar 18, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David B ReinJohn W Ward
Aug 5, 2015·BMC Gastroenterology·Sai ZhangPaul M Griffin
Oct 17, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas R O'BrienRuth M Pfeiffer
Nov 3, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexis P ChidiKenneth J Smith
Nov 27, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Sammy SaabTimothy Juday
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David B ReinJohn S Wittenborn

❮ Previous
Next ❯

Citations

Jun 4, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John K LinJeremy D Goldhaber-Fiebert
Sep 5, 2018·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Lauren E CiprianoThomas A Weber

❮ Previous
Next ❯

Software Mentioned

COSMOS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Alexis P ChidiKenneth J Smith
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
David B ReinJohn W Ward
© 2022 Meta ULC. All rights reserved